Prestige Wealth Management Group’s Amedisys AMED Stock Holding History

Prestige Wealth Management Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37	Closed	-$3.64K	–	999
2025 Q2	$3.64K	Hold	37	–	–	﹤0.01%	622
2025 Q1	$3.43K	Hold	37	–	–	﹤0.01%	637
2024 Q4	$3.36K	Hold	37	–	–	﹤0.01%	682
2024 Q3	$3.57K	Hold	37	–	–	﹤0.01%	667
2024 Q2	$3.4K	Hold	37	–	–	﹤0.01%	623
2024 Q1	$3.41K	Hold	37	–	–	﹤0.01%	657
2023 Q4	$3.52K	Sell	37 -14	-27%	-$1.31K	﹤0.01%	651
2023 Q3	$4.76K	Buy	51 +14	+38%	+$1.29K	﹤0.01%	580
2023 Q2	$3.38K	Hold	37	–	–	﹤0.01%	678
2023 Q1	$2.72K	Sell	37 -3	-8%	-$260	﹤0.01%	689
2022 Q4	$3.34K	Buy	40 +3	+8%	+$270	﹤0.01%	721
2022 Q3	$4K	Hold	37	–	–	﹤0.01%	576
2022 Q2	$4K	Sell	37 -3	-8%	-$383	﹤0.01%	618
2022 Q1	$7K	Buy	40 +3	+8%	+$448	﹤0.01%	527
2021 Q4	$6K	Hold	37	–	–	﹤0.01%	575
2021 Q3	$6K	Hold	37	–	–	﹤0.01%	580
2021 Q2	$9K	Hold	37	–	–	﹤0.01%	488
2021 Q1	$10K	Hold	37	–	–	﹤0.01%	474
2020 Q4	$11K	Hold	37	–	–	﹤0.01%	435
2020 Q3	$9K	Hold	37	–	–	﹤0.01%	452
2020 Q2	$7K	Hold	37	–	–	﹤0.01%	469
2020 Q1	$7K	Hold	37	–	–	﹤0.01%	432
2019 Q4	$6K	Hold	37	–	–	﹤0.01%	398
2019 Q3	$5K	Hold	37	–	–	﹤0.01%	406
2019 Q2	$4K	Hold	37	–	–	﹤0.01%	407
2019 Q1	$5K	Sell	37 -4	-10%	-$502	﹤0.01%	396
2018 Q4	$5K	Buy	+41	New	+$4.83K	﹤0.01%	566

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prestige Wealth Management Group's AMED Position: Q3 2025 in Review

Prestige Wealth Management Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 37 shares — an estimated $3.64K sold.

Prestige Wealth Management Group first reported a position in AMED in Q4 2018 and held it in 27 quarters. The position peaked at $11K in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Prestige Wealth Management Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Prestige Wealth Management Group sold 37 Amedisys shares in Q3 2025, an estimated $3.64K.
Prestige Wealth Management Group first reported a position in Amedisys in Q4 2018 and held it in 27 quarters.
Prestige Wealth Management Group's Amedisys position peaked at $11K in Q4 2020.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Prestige Wealth Management Group's 13F filing for Q3 2025, filed 10 Nov 2025.